Matinas BioPharma Holdings, Inc. (MTNB)
2.64
+0.22
(+9.09%)
USD |
NYAM |
Oct 02, 16:00
2.83
+0.19
(+7.20%)
After-Hours: 20:00
Matinas BioPharma Holdings Price : 2.64 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 2.53 | 2.748 | 2.421 | 2.64 | 295503.0 |
| Oct 01, 2026 | 2.58 | 2.58 | 2.36 | 2.42 | 45160.00 |
| Sep 30, 2026 | 2.72 | 2.80 | 2.444 | 2.55 | 152603.0 |
| Sep 29, 2026 | 2.47 | 3.050 | 2.40 | 2.88 | 764315.0 |
| Sep 28, 2026 | 2.47 | 2.65 | 2.34 | 2.53 | 117842.0 |
| Sep 25, 2026 | 2.580 | 2.643 | 2.313 | 2.400 | 52014.00 |
| Sep 24, 2026 | 2.625 | 2.685 | 2.568 | 2.670 | 15747.00 |
| Sep 23, 2026 | 2.662 | 2.677 | 2.514 | 2.625 | 28146.00 |
| Sep 22, 2026 | 2.602 | 2.695 | 2.550 | 2.655 | 13723.00 |
| Sep 21, 2026 | 2.400 | 2.623 | 2.400 | 2.608 | 19494.00 |
| Sep 18, 2026 | 2.449 | 2.535 | 2.370 | 2.406 | 28440.00 |
| Sep 17, 2026 | 2.370 | 2.457 | 2.323 | 2.445 | 44956.00 |
| Sep 16, 2026 | 2.418 | 2.547 | 2.328 | 2.476 | 71950.00 |
| Sep 15, 2026 | 2.854 | 2.892 | 2.258 | 2.400 | 92946.00 |
| Sep 14, 2026 | 2.850 | 2.947 | 2.763 | 2.880 | 134148.0 |
| Sep 11, 2026 | 2.850 | 3.000 | 2.700 | 2.775 | 53366.00 |
| Sep 10, 2026 | 2.793 | 3.075 | 2.716 | 3.075 | 110852.0 |
| Sep 09, 2026 | 2.730 | 2.809 | 2.724 | 2.755 | 42685.00 |
| Sep 08, 2026 | 2.829 | 2.850 | 2.704 | 2.730 | 37777.00 |
| Sep 04, 2026 | 2.761 | 2.856 | 2.595 | 2.730 | 91848.00 |
| Sep 03, 2026 | 2.880 | 2.893 | 2.595 | 2.715 | 54270.00 |
| Sep 02, 2026 | 2.901 | 2.998 | 2.776 | 2.790 | 25270.00 |
| Sep 01, 2026 | 3.000 | 3.000 | 2.812 | 2.965 | 22844.00 |
| Aug 31, 2026 | 2.920 | 2.967 | 2.806 | 2.965 | 30599.00 |
| Aug 28, 2026 | 2.977 | 3.000 | 2.896 | 3.000 | 27094.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| Price to Book Value | 0.6264 |
| Earnings Yield | -682.3% |
| Market Cap | 1.128M |